MRK

Merck & Co., Inc. NYSE

Healthcare ·Drug Manufacturers - General ·US · merck.com

$113.12

Pre-mkt $113.11 -0.02%

Mkt Cap $279.4B

52w Low $73.31 76.8% of range 52w High $125.14

50d MA $117.53 200d MA $99.89

P/E (TTM) 15.4x

EV/EBITDA 11.8x

P/B 5.3x

Debt/Equity 1.0x

ROE 34.7%

P/FCF 21.4x

RSI (14) —

ATR (14) —

Beta 0.28

50d MA $117.53

200d MA $99.89

Avg Volume 10.9M

About

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vacci…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Apr 30, 2026	BMO	-1.47	-1.28	+12.9%	110.95	-1.5%	-1.6%	+1.1%	—	—	—	—
Feb 3, 2026	BMO	2.01	2.04	+1.5%	113.37	-1.5%	+2.2%	+4.4%	+5.6%	+7.6%	+3.8%	—
Oct 30, 2025	BMO	2.36	2.58	+9.3%	86.58	-2.3%	-0.3%	-0.7%	-4.7%	-3.1%	-2.5%	—
Jul 29, 2025	BMO	2.03	2.13	+4.9%	84.06	-5.0%	-1.7%	-2.7%	-7.1%	-5.7%	-5.0%	—
Apr 24, 2025	BMO	2.13	2.22	+4.2%	78.69	-0.5%	+1.5%	+5.1%	+5.7%	+7.7%	+8.3%	—
Feb 4, 2025	BMO	1.85	1.72	-7.0%	99.79	-10.8%	-9.1%	-10.1%	-11.8%	-12.5%	-13.4%	—
Oct 31, 2024	BMO	1.50	1.57	+4.7%	104.83	-3.7%	-2.4%	-2.8%	-2.8%	-3.0%	-3.9%	—
Jul 30, 2024	BMO	2.15	2.28	+6.0%	127.78	-3.4%	-9.8%	-11.5%	-10.9%	-9.8%	-12.1%	—
Apr 25, 2024	BMO	1.88	2.07	+10.1%	127.00	+2.1%	+2.9%	+3.3%	+2.5%	+1.7%	+1.4%	—
Feb 1, 2024	BMO	-0.09	0.03	+133.3%	120.78	+2.4%	+4.6%	+4.7%	+4.5%	+5.1%	+5.5%	—
Oct 26, 2023	BMO	1.95	2.13	+9.2%	103.63	-0.5%	+1.9%	-0.8%	-0.9%	-0.9%	-0.8%	—
Aug 1, 2023	BMO	-2.17	-2.06	+5.1%	106.65	+2.8%	-1.3%	-0.9%	-0.9%	-1.5%	-0.5%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
May 1	Wells Fargo	Maintains	Overweight → Overweight	—	$109.18	$112.33	+2.9%	+2.7%	—	—	—	—
Apr 13	UBS	Maintains	Buy → Buy	—	$121.42	$121.03	-0.3%	-1.0%	-1.2%	-2.9%	-4.9%	-1.9%
Apr 6	JP Morgan	Maintains	Overweight → Overweight	—	$120.87	$120.41	-0.4%	-0.0%	-1.3%	+1.9%	+1.5%	+0.5%
Mar 30	RBC Capital	Maintains	Outperform → Outperform	—	$119.63	$120.57	+0.8%	-1.3%	+0.6%	+1.0%	+1.0%	+1.0%
Mar 20	Citigroup	Maintains	Neutral → Neutral	—	$114.20	$114.25	+0.0%	-0.0%	+1.3%	+1.9%	+4.5%	+4.1%
Mar 12	Wells Fargo	Maintains	Overweight → Overweight	—	$116.21	$115.47	-0.6%	-0.3%	-0.5%	-0.7%	-0.3%	-1.5%
Feb 9	Freedom Broker	Maintains	Hold → Hold	—	$121.93	$121.41	-0.4%	-3.5%	-3.9%	-2.2%	-2.2%	-0.4%
Feb 6	Guggenheim	Maintains	Buy → Buy	—	$119.75	$120.76	+0.8%	+1.8%	-1.8%	-2.2%	-0.4%	-0.4%
Feb 4	Cantor Fitzgerald	Maintains	Neutral → Neutral	—	$115.84	$116.90	+0.9%	+2.1%	+3.4%	+5.3%	+1.6%	+1.1%
Feb 4	Citigroup	Maintains	Neutral → Neutral	—	$115.84	$116.90	+0.9%	+2.1%	+3.4%	+5.3%	+1.6%	+1.1%
Feb 4	Wells Fargo	Maintains	Overweight → Overweight	—	$115.84	$116.90	+0.9%	+2.1%	+3.4%	+5.3%	+1.6%	+1.1%
Jan 27	Citigroup	Maintains	Neutral → Neutral	—	$107.40	$107.50	+0.1%	+0.5%	-0.5%	+0.9%	+2.7%	+5.6%
Jan 20	TD Cowen	Maintains	Hold → Hold	—	$108.83	$108.11	-0.7%	+0.6%	+2.1%	+0.3%	-0.6%	-1.3%
Jan 8	Wolfe Research	Upgrade	Peer Perform → Outperform	—	$108.60	$110.61	+1.9%	+2.2%	+1.8%	+0.5%	-0.3%	+2.2%
Jan 7	Citigroup	Maintains	Neutral → Neutral	—	$108.87	$109.51	+0.6%	-0.2%	+1.9%	+1.5%	+0.3%	-0.6%
Jan 7	UBS	Maintains	Buy → Buy	—	$108.87	$109.51	+0.6%	-0.2%	+1.9%	+1.5%	+0.3%	-0.6%
Dec 18	BMO Capital	Upgrade	Market Perform → Outperform	—	$99.18	$99.27	+0.1%	+1.5%	+1.9%	+5.6%	+5.9%	+7.3%
Dec 15	BofA Securities	Maintains	Buy → Buy	—	$100.30	$99.99	-0.3%	-0.0%	-2.0%	-1.1%	+0.4%	+0.8%
Dec 12	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$99.01	$98.96	-0.1%	+1.3%	+1.3%	-0.7%	+0.2%	+1.7%
Dec 4	Scotiabank	Maintains	Sector Outperform → Sector Outperform	—	$102.27	$102.10	-0.2%	-1.3%	-2.5%	-3.3%	-5.3%	-4.5%
Dec 2	Goldman Sachs	Maintains	Buy → Buy	—	$101.83	$101.53	-0.3%	-0.8%	+0.4%	-0.9%	-2.1%	-2.8%
Nov 24	Wells Fargo	Upgrade	Equal Weight → Overweight	—	$97.76	$99.12	+1.4%	+2.7%	+8.1%	+7.0%	+7.2%	+4.2%
Nov 18	Deutsche Bank	Maintains	Hold → Hold	—	$92.86	$94.11	+1.3%	+3.8%	+2.4%	+2.3%	+5.3%	+8.1%
Nov 3	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$85.98	$85.77	-0.2%	-4.1%	-2.5%	-1.8%	-0.2%	+0.3%
Sep 17	Berenberg	Downgrade	Buy → Hold	—	$81.09	$80.98	-0.1%	+0.1%	+0.5%	+0.5%	-0.9%	-1.4%
Jul 30	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$82.63	$82.91	+0.3%	-1.1%	-5.5%	-4.0%	-3.4%	-2.2%
Jul 10	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$83.71	$83.64	-0.1%	+0.4%	-0.4%	-0.0%	-2.6%	-1.5%
May 14	Citigroup	Downgrade	Buy → Neutral	—	$76.63	$77.46	+1.1%	-4.1%	-2.4%	-0.7%	+0.8%	+1.7%
Apr 17	Guggenheim	Maintains	Buy → Buy	—	$76.46	$76.89	+0.6%	+2.0%	+1.8%	+3.3%	+2.9%	+4.4%
Feb 18	Deutsche Bank	Downgrade	Buy → Hold	—	$83.01	$81.13	-2.3%	+0.3%	+3.1%	+5.6%	+7.8%	+10.0%
Feb 12	Guggenheim	Maintains	Buy → Buy	—	$86.54	$86.07	-0.5%	-1.0%	-2.4%	-4.1%	-3.8%	-1.1%
Feb 5	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$90.74	$90.39	-0.4%	-1.2%	-3.0%	-3.8%	-4.8%	-4.6%
Feb 5	BMO Capital	Maintains	Market Perform → Market Perform	—	$90.74	$90.39	-0.4%	-1.2%	-3.0%	-3.8%	-4.8%	-4.6%
Feb 5	BofA Securities	Maintains	Buy → Buy	—	$90.74	$90.39	-0.4%	-1.2%	-3.0%	-3.8%	-4.8%	-4.6%
Feb 5	Citigroup	Maintains	Buy → Buy	—	$90.74	$90.39	-0.4%	-1.2%	-3.0%	-3.8%	-4.8%	-4.6%
Jan 28	Citigroup	Maintains	Buy → Buy	—	$97.94	$97.35	-0.6%	-0.5%	+0.3%	+1.0%	+0.9%	+1.9%
Jan 21	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$97.92	$98.08	+0.2%	-1.7%	-2.3%	-1.3%	-2.4%	+0.0%
Jan 17	Guggenheim	Maintains	Buy → Buy	—	$100.70	$100.47	-0.2%	-2.8%	-4.4%	-5.0%	-4.0%	-5.1%
Jan 13	Leerink Partners	Maintains	Outperform → Outperform	—	$99.25	$99.46	+0.2%	+1.7%	+0.4%	+0.8%	+1.5%	-1.3%
Jan 8	UBS	Maintains	Buy → Buy	—	$101.02	$100.70	-0.3%	-1.2%	-1.8%	-0.0%	-1.4%	-0.9%
Jan 8	Truist	Downgrade	Buy → Hold	—	$101.02	$100.70	-0.3%	-1.2%	-1.8%	-0.0%	-1.4%	-0.9%
Dec 20	BMO Capital	Downgrade	Outperform → Market Perform	—	$99.52	$98.83	-0.7%	-1.5%	-0.2%	-0.1%	+0.4%	+0.2%
Nov 7	Truist	Maintains	Buy → Buy	—	$100.73	$101.44	+0.7%	+0.4%	+2.2%	+0.0%	-2.1%	-2.2%
Nov 6	Guggenheim	Maintains	Buy → Buy	—	$101.65	$103.18	+1.5%	-0.9%	-0.5%	+1.2%	-0.9%	-3.0%
Nov 1	BMO Capital	Maintains	Outperform → Outperform	—	$102.32	$101.78	-0.5%	-0.4%	-0.4%	-0.7%	-1.6%	-1.1%
Nov 1	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$102.32	$101.78	-0.5%	-0.4%	-0.4%	-0.7%	-1.6%	-1.1%
Nov 1	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$102.32	$101.78	-0.5%	-0.4%	-0.4%	-0.7%	-1.6%	-1.1%
Oct 25	Citigroup	Maintains	Buy → Buy	—	$105.88	$106.49	+0.6%	-1.8%	-1.6%	-2.0%	-1.0%	-3.4%
Oct 9	UBS	Maintains	Buy → Buy	—	$108.52	$108.41	-0.1%	+1.6%	+0.8%	+1.1%	+1.1%	+2.8%
Oct 9	Truist	Maintains	Buy → Buy	—	$108.52	$108.41	-0.1%	+1.6%	+0.8%	+1.1%	+1.1%	+2.8%

Recent Filings

SC TO-T !!! Very High

Terns Pharmaceuticals, Inc. -- Tender Offer

Merck is acquiring Terns Pharmaceuticals for $53 per share in a tender offer, gaining access to Terns' pipeline of metabolic disease treatments and expanding its pharmaceutical portfolio.

Apr 24

SC TO-T !!! Very High

Unknown — Tender Offer

Merck's tender offer for Tern Pharmaceuticals signals acquisition intent, potentially indicating confidence in Tern's pipeline value and providing Tern shareholders with liquidity while offering Merck near-term asset diversification.

Apr 7

8-K

Merck & Co., Inc. -- 8-K Filing

Merck projects 2026 sales of $65.5-$67.0 billion and non-GAAP EPS of $5.00-$5.15, with a $3.65-per-share charge from its Cidara acquisition, signaling measured growth expectations.

Feb 3

Data updated apr 26, 2026 1:13pm · Source: massive.com